Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind Trial Comparing Linezolid To Vancomycin In The Empiric Treatment Of Febrile Neutropenic Oncology Patients With Suspected Gram-Positive Infections

NCT00035425 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00035425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00035425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind Trial Comparing Linezolid To Vancomycin In The Empiric Treatment Of Febrile Neutropenic Oncology Patients With Suspected Gram-Positive Infections
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2001
Completion date
November 30, 2002
Enrollment
120 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

febrile neutropenia